title: Rapid infliximab infusions are generally well-tolerated in children with inflammatory bowel disease.
authors.affiliation: Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.
authors.forename: Caitlin
authors.initials: C
authors.lastname: Glover
authors.affiliation: Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.
authors.forename: Linny
authors.initials: L
authors.lastname: Phuong
authors.affiliation: Department of Paediatrics, Monash University, Melbourne, Victoria, Australia.|Department of Gastroenterology, Monash Children's Hospital, Melbourne, Victoria, Australia.
authors.forename: Rupert
authors.initials: R
authors.lastname: Hinds
mesh_terms: D000293:Adolescent; D002648:Child; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab / Q000008:administration & dosage* / Q000627:therapeutic use; D007262:Infusions, Intravenous / Q000379:methods*
chemical_list: D005765:Gastrointestinal Agents; D000069285:Infliximab